|
Issue |
Title |
|
Vol 25, No 1 (2024) |
Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis |
Details
HTML
PDF
|
Lorenzo Mantovani, Paolo Angelo Cortesi, Michele Molina, Laura Santoni, Luca Prosperini |
|
Vol 23, No 1 (2022) |
Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy |
Abstract
HTML
PDF
|
Edoardo Mannucci, Gianni Ghetti |
|
Vol 15, No 4 (2014) |
Cost-effectiveness of intravitreal therapy in Age-Related Macular Degeneration |
Abstract
HTML
PDF
|
Piergiorgio Neri, Ilir Arapi, Chiara Maria Eandi, Vittorio Pirani, Cesare Mariotti, Alfonso Giovannini |
|
Vol 15, No 1 (2014) |
Cost-effectiveness of tenofovir in the treatment of patients with chronic hepatitis B: data from literature |
Abstract
HTML
PDF
|
Massimo Fasano, Giorgio L. Colombo, Sergio Di Matteo, Claudia Randazzo, Gioacchino Angarano, Teresa Antonia Santantonio |
|
Vol 17, No 3 (2016) |
Cost-effectiveness profile, organizational implications and patient preferences on the use of exogenous TSH therapy (Thyrogen®) vs. THW in thyroid residue ablation in Italy |
Abstract
HTML
PDF
|
Gianluca De Danieli, Fabio Monari, Renzo Lazzarini, Filippo Cipriani |
|
Vol 9, No 3 (2008) |
Cost-efficacy analysis of hormonal treatments for advanced prostate cancer |
Abstract
PDF
|
Sergio Iannazzo, Lorenzo Pradelli |
|
Vol 3, No 2 (2002) |
Costi del trattamento con oloprazina nelle fasi iniziali della schizofrenia |
Abstract
PDF
|
Domenico Berardi, Maddalena Dell’Atti, Francesca Russo, Virginia Vagnini, Luca Guidi, Eric T. Edgell |
|
Vol 6, No 2 (2005) |
Costi e bisogni sanitari degli anziani non autosufficienti presso le strutture residenziali: strategie e interventi per una popolazione che invecchia |
Abstract
PDF
|
Marta Moro, Chiara Salvato, Gianni Terrazzani, Donatella Serraglia, Cristina Saramin, Pietro Giusti, Alessandro Chinellato |
|
Vol 5, No 1 (2004) |
Costi ed effetti di Risperidone Long Acting (RLA) rispetto ad antipsicotici atipici nel trattamento dei soggetti schizofrenici in Italia |
Abstract
PDF
|
Lorenzo G. Mantovani, Patrizia Berto, Anna D. Ausilio, Bart Heeg |
|
Vol 4, No 1 (2003) |
Costi sanitari di un programma vaccinale: analisi di minimizzazione dei costi |
Abstract
PDF
|
G. L. Colombo, A. Muzio, R. Giordani |
|
Vol 6, No 3 (2005) |
Costo/efficacia della prevenzione di infezioni alle prime vie aeree mediante un estratto batterico immunostimolante aspecifico (OM-85) |
Abstract
PDF
|
Orietta Zaniolo, Lorenzo Pradelli, Mario Eandi |
|
Vol 5, No 1 (2004) |
Costo-efficacia dell’amfotericina B liposomiale nella terapia dell’aspergillosi invasiva |
Abstract
PDF
|
Mario Eandi |
|
Vol 2, No 1 (2001) |
Costruzione di un modello decisionale per valutare la costo/efficacia delle strategie alternative nella terapia della polmonite acquisita in comunità |
Abstract
PDF
|
Mario Eandi |
|
Vol 8, No 2 (2007) |
Costs and efficacy ofolanzapine and risperidone in schizophrenia |
Abstract
PDF
|
Vittorio Mapelli |
|
Vol 10, No 2 (2009) |
Costs of diabetes in Italy |
Abstract
PDF
|
Orietta Zaniolo |
|
Vol 14, No 2 (2013) |
Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model |
Abstract
HTML
PDF
|
Mario Eandi, Lorenzo Pradelli, Massimiliano Povero |
|
Vol 9, No 1 (2008) |
Cost-utility analysis of abatacept in rheumatoid arthritis in Italy |
Abstract
PDF
|
Simona de Portu, Lorenzo Giovanni Mantovani, Ignazio Olivieri |
|
Vol 15, No 4 (2014) |
Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients |
Abstract
HTML
PDF
|
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro |
|
Vol 15, No 3 (2014) |
Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy |
Abstract
HTML
PDF
|
Craig Bennison, Stephanie Stephens, Giario Natale Conti |
|
Vol 13, No 1 (2012) |
Could the choice of patient versus proxy ratings for assessing quality of life in dementia affect resource allocation in health care? |
Abstract
HTML
PDF
|
Jenny Alwin, Thor-Henrik Brodtkorb |
|
Vol 1, No 1 (2000) |
Creare Valore Sanitario: nuove prospettive per il management delle aziende sanitarie |
Abstract
PDF
|
Giorgio Donna, Salvatore Nieddu |
|
Vol 1, No 2 (2000) |
Creazione di valore sanitario e sistemi di finanziamento: il caso del dipartimento di salute mentale |
Abstract
PDF
|
Carmine Munizza, Salvatore Nieddu |
|
Vol 21, No 1 (2020) |
Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa |
Abstract
HTML
PDF
|
Matteo Nicola Dario Di Minno, Lucia D'Angiolella, Paolo Angelo Cortesi, Angelo Claudio Molinari, Lorenzo Giovanni Mantovani |
|
Vol 10, No 3 (2009) |
Dabigatran in the prevention of venous thromboembolism after major orthopedic surgery |
Abstract
PDF
|
Orietta Zaniolo |
|
Vol 9, No 3 (2008) |
Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections |
Abstract
PDF
|
Viola Sacchi |
|
Vol 25, No 1 (2024) |
Decatecholaminization of Septic Shock Patients in Intensive Care Unit: an Economic Assessment in the Italian Setting |
Abstract
HTML
PDF
|
Alfredo Del Gaudio, Assunta Caiazza, Luana Bortone, Sonia Tomasso, Ilaria Bozzari, Laura Vincenzi, Gianluca Furneri, Luigi Tritapepe |
|
Vol 9, No 2 (2008) |
Decision analytic economic paliperidone ER in relapsing schizophrenic patients in Italy |
Abstract
PDF
|
Patrizia Berto, Cristina Negrini, Luigi Ferrannini |
|
Vol 17, No 2 (2016) |
Demand for healthcare by the elderly in developing countries |
Details
HTML
PDF
|
Yinka Kehinde Binuomoyo, Abimbola Oluseyi Ogunsola |
|
Vol 12, No 2S (2011) |
DENALI: il Data Warehouse di Sanità Pubblica della Regione Lombardia |
Details
PDF
|
Giancarlo Cesana, Carla Fornari, Virginio Chiodini, Fabiana Madotto, Luca Merlino, Lorenzo G. Mantovani |
|
Vol 20, No 1 (2019) |
Developing a Model for the Establishment of Pre-Hospital Emergency Medicine Bases in the Northern Provinces of Iran |
Abstract
HTML
PDF
|
Azadeh Ahmadi Dashtiyan, Iravan Masoudi Asl, Leila Riahi, Mahmood Mahmoodi |
|
Vol 14, No 4 (2013) |
Direct medical costs of COPD diagnosis and treatment, Eastern vs Western European country – examples of Serbia and Belgium |
Abstract
HTML
PDF
|
Mihajlo B Jakovljevic, Zorica Lazic, Nick Verhaeghe, Slobodan Jankovic, Olgica Gajovic, Lieven Annemans |
|
Vol 4, No 2 (2003) |
Durata e costo delle visite in medicina generale: il progetto DYSCO |
Abstract
PDF
|
Livio Garattini, Emanuela Castelnuovo, Davide Lanzeni, Cecilia Viscarra, DYSCO VISITE Gruppo di studio DYSCO VISITE |
|
Vol 1, No 2 (2000) |
È possibile coniugare risparmio e miglioramento nelle aziende USL? |
Abstract
PDF
|
Sergio Sabbatani |
|
Vol 7, No 4 (2006) |
Economic and clinical value of levofloxacin |
Abstract
PDF
|
Mario Eandi, Orietta Zaniolo |
|
Vol 15, No 3 (2014) |
Economic burden of Communicable and Non-communicable Diseases in Jamaica: Is our research focus where it should be? |
Details
HTML
PDF
|
Christine Fray-Aiken |
|
Vol 23, No 1 (2022) |
Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis |
Abstract
HTML
PDF
|
Marco Bellone, Lorenzo Pradelli, Rita Tavarozzi, Marco Ladetto, Giuliana Nepoti, Emanuele Guardalben, Daniela Ghislieri |
|
Vol 10, No 3 (2009) |
Economic crisis and consumption of medical resources in Italy |
Details
PDF
|
Mario Eandi |
|
Vol 20, No 1 (2019) |
Economic Evaluation of Different Organizational Models for the Management of Patients with Hepatitis C |
Abstract
HTML
PDF
|
Stefano Fagiuoli, Luisa Pasulo, Franco Maggiolo, Rosaria Spinella, Paolo Del Poggio, Roberto Boldizzoni, Mariella Di Marco, Alessandro Aronica, Chiara Benedetti, Paolo Correale, Chiara Garavaglia, Carlo Nicora |
|
Vol 10, No 2 (2009) |
Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study |
Abstract
PDF
|
Simona de Portu, Giacomo Carteni, Andrea Belisari |
|
Vol 7, No 3 (2006) |
Economic evaluation of the CARDS study |
Abstract
PDF
|
Simona de Portu, Enrica Menditto, Lorenzo G. Mantovani |
|
Vol 14, No 3 (2013) |
Economic evaluation of the chronic hepatitis B treatment strategies in Italy |
Abstract
HTML
PDF
|
Sergio Iannazzo, Barbara Coco, Maurizia Brunetto, Francesca Rossetti, Antonietta Caputo, Maria De Francesco, Ferruccio Bonino |
|
Vol 11, No 2 (2010) |
Economic evaluation of the use of saxagliptin in the treatment of type 2 diabetes in Italy |
Abstract
PDF
|
Marco Cristiani, Anna Citarella, Andrea Belisari, Guido Didoni, Lorenzo Giovanni Mantovani, Sabato Montella |
|
Vol 15, No 4 (2014) |
Economic impact of the use of Hyalubrix® in the treatment of hip osteoarthritis in Italy |
Abstract
HTML
PDF
|
Alberto Migliore, Andrea Belisari, Lucia S. D'Angiolella, Emanuele Bizzi, Umberto Massafra, Prisco Piscitelli, Lorenzo Giovanni Mantovani |
|
Vol 18, No 1 (2017) |
Economic implications in inflammatory bowel disease: results from a retrospective analysis in an Italian Centre |
Abstract
HTML
PDF
|
Angela Variola, Arianna Massella, Andrea Geccherle, Paolo Bocus, Roberto Tessari, Teresa Zuppini, Roberto Ravasio |
|
Vol 19, No 1 (2018) |
Editorial Staff Disclosure (2018) |
Details
HTML
PDF
|
Ombretta Bandi |
|
Vol 10, No 4 (2009) |
Effectiveness and cost of treatment with maraviroc in HIV infection |
Abstract
PDF
|
Viola Sacchi, Lorenzo Pradelli |
|
Vol 20, No 1 (2019) |
Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations |
Abstract
HTML
PDF
|
Orietta Zaniolo, Gianni Ghetti, Massimiliano Povero, Lorenzo Pradelli |
|
Vol 3, No 1 (2002) |
Efficienza tecnologica e produttiva delle strutture trasfusionali in Italia |
Abstract
PDF
|
Dante Cornago, Livio Garattini |
|
Vol 13, No 2S (2012) |
Emilia Romagna |
Abstract
HTML
PDF
|
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni |
|
Vol 9, No 1S (2008) |
Emilia Romagna |
Abstract
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 9, No 3 (2008) |
Entecavir (Baraclude) in patients with chronic hepatitis B virus (HPV) infection |
Abstract
PDF
|
Viola Sacchi |
|
Vol 12, No 2S (2011) |
Epidemiologia, prevenzione e trattamento delle malattie cardiovascolari: evidenze dal database della medicina generale |
Details
PDF
|
Giampiero Mazzaglia, Alessandro Filippi, Lorenzo G. Mantovani, Gianluca Furneri, Carlo Niccolai, Jacopo Cricelli, Achille P. Caputi, Ovidio Brignoli, Claudio Cricelli |
|
Vol 9, No 2 (2008) |
Epidemiological and economic aspects of diabetes in the Campania Region, Italy |
Abstract
PDF
|
Simona Cammarota, Andrea Morsanutto, Enrica Menditto, Anna Citarella, Simona de Portu |
|
Vol 9, No 4 (2008) |
Epidemiology and costs of HPV infection: review of the evidence |
Abstract
PDF
|
Francesco Bamfi, Alessia Marocco, Stefano Capri, Mario Giovanni Sideri |
|
Vol 18, No 1 (2017) |
Equilibrium between resources and expenditure of health sector of Social Security Fund: a case study of Iran |
Abstract
HTML
PDF
|
Azadeh Ahmadi Dashtian, Mohsen Mardali |
|
Vol 11, No 2 (2010) |
Equity of access to innovative drugs and sustainability of pharmaceutical expenditure |
Details
PDF
|
Mario Eandi |
|
Vol 7, No 1 (2006) |
Errata corrige: “Valutazione clinica e metabolica dell’impiego dell’insulina Lispro in pazienti con diabete mellito scompensato” |
Details
PDF
|
Antonio Uneddu, Tito Antonio Paolini |
|
Vol 20, No 1 (2019) |
Erratum: Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations |
Abstract
HTML
PDF
|
[No authors listed] |
|
Vol 13, No 3S (2012) |
Essential to increase the use of generics in Europe to maintain comprehensive health care? |
Abstract
HTML
PDF
|
Brian Godman, Marion Bennie, Christoph Baumgärtel, Ljiljana Sović-Brkičić, Thomas Burkhardt, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Vanda Markovic-Pekovic, Andrew Martin, Catherine Sermet, Peter Skiold, Menno van Woerkom, Luka Voncina, Lars L. Gustafsson |
|
Vol 19, No 1 (2018) |
Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation |
Abstract
HTML
PDF
|
Marco Bellone, Lorenzo Pradelli, Mario Bo |
|
Vol 12, No 1 (2011) |
Estimation of economic consequences of GOLD guidelines adoption in the Italian clinical practice |
Abstract
PDF
|
Orietta Zaniolo, Germano Bettoncelli, Giancarlo Bosio, Lorenzo Mantovani, Riccardo Pistelli, Adriano Vaghi, Marco Villa, Sergio Iannazzo, Francesco Bamfi, Vincenzo Frizzo, Roberto Walter Dal Negro |
|
Vol 14, No 2 (2013) |
European and Italian regulation on orphan medicinal products |
Abstract
HTML
PDF
|
Roberta Joppi |
|
Vol 7, No 1 (2006) |
European health information system and cardiovascular diseases |
Details
PDF
|
Mario Eandi |
|
Vol 9, No 1 (2008) |
Evaluation of antimicrobial consumption in Campania Region, Italy |
Abstract
PDF
|
Simona Cammarota, Anna Citarella, Enrica Menditto, Simona de Portu |
|
Vol 9, No 1 (2008) |
Evaluation of health resources expenditure in two groups of psychotic patients treated with olanzapine and typical neuroleptics in a Italian Mental Health Department in Calabria Region |
Abstract
PDF
|
Anna Caputo, Luca Guidi, Giovanni Biricolti, Sergio Torchia |
|
Vol 20, No 1 (2019) |
Evaluation of patients treated for diabetic retinopathy: an analysis of the administrative databases of the Lazio Region |
Abstract
HTML
PDF
|
Francesco Mennini, Lorella Lombardozzi, Alessandra Mecozzi, Paolo Sciattella |
|
Vol 18, No 1 (2017) |
Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets |
Abstract
HTML
PDF
|
Cristina Negrini, Emi Psachoulia |
|
Vol 9, No 3 (2008) |
Evolution of global drug market and amrket access |
Details
PDF
|
Mario Eandi |
|
Vol 6, No 4 (2005) |
Evoluzione del mercato farmaceutico nei primi nove mesi del 2005 |
Details
PDF
|
Mario Eandi |
|
Vol 4, No 1S (2003) |
Evoluzione storica della farmacoutilizzazione degli anti-ipertensivi in Italia (1988-1998) |
Abstract
PDF
|
Enrico Bologna, Pierluigi Russo, Sabrina Licata, Liliana Civalleri, Luciano Caprino |
|
Vol 15, No 2 (2014) |
Experiences of including costs of added life years in health economic evaluations in Sweden |
Abstract
HTML
PDF
|
Laura Pirhonen, Thomas Davidson |
|
Vol 21, No 1 (2020) |
Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective |
Abstract
HTML
PDF
|
Daniela Paola Roggeri, Ezio Zanon, Chiara Biasoli, Alessandro Roggeri |
|
Vol 4, No 4 (2003) |
Farmaci antipertensivi a confronto: costi e benefici per il paziente e la collettività |
Abstract
PDF
|
Francesco Vittorio Costa |
|
Vol 2, No 4 (2001) |
Farmaci orfani e malattie rare: la situazione in Italia |
Abstract
|
S. Martina, C. Denti, E. Daina, L. Garattini |
|
Vol 2, No 3 (2001) |
Farmaci orfani e malattie rare: un confronto internazionale delle normative di riferimento |
Abstract
PDF
|
S. Martina, C. Denti, L. Garattini |
|
Vol 4, No 1S (2003) |
Farmacoeconomia dei COXIB nella patologia osteoarticolare: revisione della letteratura |
Abstract
PDF
|
Pierluigi Russo, Luca Degli Esposti, Alessandro Capone, Ezio Degli Esposti, Luciano Caprino |
|
Vol 8, No 2S (2007) |
Farmacoeconomia e malattie cardiovascolari |
Details
PDF
|
Lorenzo G. Mantovani, Andrea Morsanutto, Simona De Portu |
|
Vol 5, No 3 (2004) |
Farmacoeconomia e outcomes research |
Abstract
PDF
|
Ermanno Attanasio |
|
Vol 5, No 4 (2004) |
Farmacoeconomia ed etica: cure sostenibili e rispetto della persona |
Abstract
PDF
|
Antonio G. Spagnolo, Roberta Minacori |
|
Vol 4, No 1S (2003) |
Farmacoepidemiologia e farmacoeconomia della terapia anti-ipertensiva: uno studio osservazionale della popolazione della Asl di Ravenna |
Abstract
PDF
|
Luca Degli Esposti, Alessandro Capone, Mirko Di Martino, Stefania Saragoni, Samuele Berlini, Pierluigi Russo, Ezio Degli Esposti |
|
Vol 7, No 3 (2006) |
First drug utilization data related to an anticholinergic agent recently marketed in Italy |
Abstract
PDF
|
Carlo Lucioni, S. Mazzi, C. Cerra, S. Lottaroli |
|
Vol 14, No 2 (2013) |
First-line HIV treatment: evaluation of backbone choice and its budget impact |
Abstract
HTML
PDF
|
Orietta Zaniolo, Massimiliano Povero, Paolo Bonfanti, Marco Borderi, Massimo Medaglia |
|
Vol 4, No 3 (2003) |
Fluoxetina: profilo terapeutico e farmacoeconomico di un prodotto generico |
Abstract
PDF
|
Carlo Della Pepa, Mario Eandi |
|
Vol 2, No 3 (2001) |
Fluvoxamina: profilo farmacoeconomico |
Abstract
PDF
|
Mario Eandi |
|
Vol 6, No 3 (2005) |
Forme galeniche e qualità di vita: il caso di tramadolo |
Abstract
PDF
|
Orietta Zaniolo |
|
Vol 9, No 1S (2008) |
Friuli Venezia Giulia |
Abstract
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 13, No 2S (2012) |
Friuli-Venezia Giulia |
Abstract
HTML
PDF
|
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni |
|
Vol 13, No 3S (2012) |
From generic to biosimilar drugs: why take an innovative pace? |
Abstract
HTML
PDF
|
Fereshteh Barei, Claude Le Pen, Steven Simoens |
|
Vol 21, No 1 (2020) |
Funding Innovation Thanks to Anti-TNF-α Biosimilars Uptake: The Economic Impact in Italy |
Abstract
HTML
PDF
|
Massimiliano Povero, Lorenzo Pradelli |
|
Vol 11, No 2 (2010) |
Fungal infections today: size of the problem and focus on the initial cost of therapy with echinocandin |
Abstract
PDF
|
Mario Venditti |
|
Vol 12, No 2 (2011) |
Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR+ |
Abstract
HTML
PDF
|
Viola Sacchi |
|
Vol 13, No 3S (2012) |
Generic and biosimilar medicines: quid? |
Abstract
HTML
PDF
|
Steven Simoens |
|
Vol 6, No 4 (2005) |
Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea |
Abstract
PDF
|
Lorenzo Pradelli |
|
Vol 4, No 1 (2003) |
Gli inibitori della pompa protonica nelle patologie acido correlate: il ruolo di rabeprazolo in una strategia di cost-minimisation |
Abstract
PDF
|
Giorgio L. Colombo, Andrea Muzio |
|
Vol 2, No 4 (2001) |
Gli studi di “cost of illness” in Italia: una review della letteratura |
Abstract
|
Andrea Bracco |
|
Vol 15, No 1 (2014) |
GOLD guidelines adherence impact on the NHS budget |
Abstract
HTML
PDF
|
Alessandro Guasconi, Claudio Ripellino, Franca Heiman |
|
Vol 9, No 4 (2008) |
Growing impact of pharmacogenomic on drug development and personalized medicine |
Details
PDF
|
Mario Eandi |
|
Vol 12, No 2S (2011) |
Health Technology Assessment |
Details
PDF
|
Lorenzo G. Mantovani, Giuseppe La Torre, Giancarlo Cesana, Walter Ricciardi |
|
Vol 22, No 1S (2021) |
Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant |
Abstract
HTML
PDF
|
Paolo Angelo Cortesi, Giovanni Luca Botto, Lucia D'Angiolella, Luciana Scalone, Roberto De Ponti, Giuseppe Boriani, Lorenzo Giovanni Mantovani |
|
Vol 19, No 1 (2018) |
Healthcare Resources Use in Patients with Human Immunodeficiency Virus (HIV). Real-World Evidence From Six Italian Local Health Units |
Abstract
HTML
PDF
|
Valentina Perrone, Diego Sangiorgi, Stefano Buda, Margherita Andretta, Silvio Borrè, Chiara Cattaruzzi, Gina Gasperini, Fabio Lena, Alessia Pisterna, Luca Degli Esposti |
|
101 - 200 of 481 Items |
<< < 1 2 3 4 5 > >> |